News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medtronic, Inc. (MDT)’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011


11/4/2011 9:15:07 AM

MINNEAPOLIS--(BUSINESS WIRE)--Offering the broadest range of medical technology for the interventional and surgical treatment of cardiovascular disease, Medtronic, Inc. (NYSE: MDT) today highlighted scientific sessions of interest on the program for TCT 2011, which takes place Nov. 7–11 in San Francisco. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES